Hanmi shares obesity drug approval has led to a sharp reversal. What does this mean for investors?
Capricor DMD therapy faces challenges as the company launches a legal fight ahead of the FDA review.
Hanmi shares obesity drug approval has led to a sharp reversal. What does this mean for investors?
Capricor DMD therapy faces challenges as the company launches a legal fight ahead of the FDA review.
